期刊
HUMAN IMMUNOLOGY
卷 82, 期 9, 页码 649-658出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2021.05.001
关键词
COVID-19; SARS-CoV-2; Spike protein; ACE2; TLR; Drugs; Vaccines; Plasma-therapy; Immunomodulation
类别
The COVID-19 pandemic originated in Wuhan and has spread globally, causing millions of deaths with no credible cure yet. Chemotherapeutic and immunotherapeutic approaches are promising strategies for the management and potential cure, aiming to interrupt virus-host interactions and modulate host immunity to combat the virus and restore immune homeostasis. Combinatorial therapy involving chemotherapy and vaccines may offer hope to eradicate the crisis.
The nCOVID-19 pandemic initiated its course of contagion from the city of Wuhan and now it has spread all over the globe. SARS-CoV-2 is the causative virus and the infection as well as its symptoms are distributed across the multi-organ perimeters. Interactions between the host and virus governs the induction of 'cytokine storm' resulting various immunopathological consequences leading to death. Till now it has caused tens of millions of casualties and yet no credible cure has emerged to vision. This article presents a comprehensive overview on the two most promising remedial approaches that are being attempted for the management, treatment, and plausible cure of nCOVID-19. In this context, chemotherapeutic approach primarily aims to interrupt the interactions between the host and the virus causing inhibition of its entry into the host cell and/or its proliferation and suppressing the inflammatory milieu in the infected patients. On the other side, immunotherapeutic approaches aim to modulate the host immunity by fine tuning the inflammatory signaling cascades to achieve phylaxis from the virus and restoring immune-homeostasis. Considering most of the path-breaking findings, combinatorial therapy involving of chemotherapeutics as well as vaccine could usher to be a hope for all of us to eradicate the crisis (c) 2021 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据